Arrowhead Pharmaceuticals Inc.
History
| Year | Detail |
|---|---|
| 2004 | Arrowhead Pharmaceuticals Inc., a biopharmaceutical company, was founded in 2004 and is headquartered in Pasadena, California. |
| 2015 | Arrowhead Pharmaceuticals Inc. acquired Novartis’ entire RNAi research and development portfolio, along with related assets. The acquisition included the transfer of certain patents and patent applications associated with RNAi therapeutics, an exclusive license to additional RNAi-related patents owned or controlled by Novartis, the assignment of a third-party license, three preclinical RNAi candidates, and other associated assets. |
| 2022 | Arrowhead Pharmaceuticals Inc. announced the formation of a joint venture, Visirna Therapeutics, with Vivo Capital to expand access to innovative RNAi-based medicines across Greater China. The partnership aims to accelerate the development and commercialization of advanced therapeutics to address unmet medical needs in the region. |